Detailed View
BIO - Bio-Rad Laboratories, Inc.
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
7,829,640,704
Adj EBIT (TTM)
245,900,000
Enterprise Value
7,076,940,704
Last Price
292.57
Earnings Yield
3.47%
Return on Capital
3.02%
Capital
8,129,100,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 592,100,000 | 34,100,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 693,200,000 | 53,900,000 |
| 2025-09-30 | 10-Q | 2025 | 653,000,000 | 65,300,000 |
| 2025-06-30 | 10-Q | 2025 | 651,600,000 | 77,100,000 |
| 2025-03-31 | 10-Q | 2025 | 585,400,000 | 23,700,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 667,524,000 | 58,330,000 |
| 2024-09-30 | 10-Q | 2024 | 649,700,000 | 64,466,000 |
| 2024-06-30 | 10-Q | 2024 | 638,476,000 | 101,496,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.